Stay updated on TACTI-002: IMP321 Combo Study NSCLC HNSCC Clinical Trial
Sign up to get notified when there's something new on the TACTI-002: IMP321 Combo Study NSCLC HNSCC Clinical Trial page.

Latest updates to the TACTI-002: IMP321 Combo Study NSCLC HNSCC Clinical Trial page
- Check2 days agoChange DetectedUpdated the clinical trial record by revising key sections including Study Status, Contacts/Locations, Participant Flow, Baseline Characteristics, and Adverse Events in the latest submitted versions. A prior entry dated 2024-12-18 was removed from the version history.SummaryDifference0.7%

- Check10 days agoChange DetectedAdded Revision: v3.5.2 to the history. Removed Revision: v3.5.0 from the history.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check38 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the study record history.SummaryDifference0.1%

- Check45 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3. No study details or essential page content appear to be affected.SummaryDifference0.2%

- Check52 days agoChange DetectedLatest version updates core study information, including recruitment status and study description. It also adjusts listed locations and contact details.SummaryDifference0.1%

- Check74 days agoChange DetectedA new site release, Revision: v3.4.2, was added. The lapse in government funding notice and Revision: v3.4.1 were removed.SummaryDifference0.6%

Stay in the know with updates to TACTI-002: IMP321 Combo Study NSCLC HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TACTI-002: IMP321 Combo Study NSCLC HNSCC Clinical Trial page.